Cancers Treated:
Positions
Roswell Park Care Network
- Medical Director
- Roswell Park Hematology Oncology Northtowns
Background
Education and Training
- 1987 - MD - Dow Medical College, Karachi, Pakistan
Residency
- 1991 - Internal Medicine - Aga Khan University Hospital, Karachi, Pakistan
Fellowship
- 1996 - Medical Oncology - Roswell Park Cancer Institute, Buffalo, NY
- 1994 - Medical Oncology - St. Luke's Hospital, St. Louis, MO
Board Certification
- 1997 - American Board of Internal Medicine/Oncology
- 1994 - American Board of Internal Medicine
Professional Memberships
- American Medical Association
- American Society of Clinical Oncology
- Erie County Medical Society
Featured on CancerTalk
Publications
- Sher T, Ailawadhi S, Miller KC, Manfredi D, Wood M, Tan W, Wilding G, Czuczman MS, Hernandez-Ilizaliturri FJ, Hong F, Sood R, Soniwala S, Lawrence W, Jamshed S, Masood A, Iancu D, Lee K, Chanan-Khan A. A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. Br J Haematol. 2011 Jul;154(1):104-10. doi: 10.1111/j.1365-2141.2011.08703.x. Epub 2011 May 9. PMID: 21554260; PMCID: PMC4078729.